Skip to content

A Comparative Study of Fractional Microneedle Radiofrequency and Microfocused Ultrasound with Visualization for Periorbital Rejuvenation: A Pilot Study

A Comparative Study of Fractional Microneedle Radiofrequency and Microfocused Ultrasound with Visualization for Periorbital Rejuvenation: A Pilot Study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260701003
Enrollment
20
Registered
2026-07-01
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periorbital wrinkle Periorbital skin aging Periorbital skin rejuvenation Microneedle radiofrequency

Interventions

Virtue radiofrequency (RF) microneedling platform designed for tissue tightening, scar revision, and overall skin rejuvenation. It combines mechanical microneedling with targeted RF energy delivered d
Experimental Device,Active Comparator Device
Virtue Radiofrequency Microneedling,Ultherapy

Sponsors

Laser Engineer Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Male or female, aged 18 years or older 2. In good general health with no serious underlying medical conditions 3. Exhibits a similar degree of skin aging around both eyes 4. No active skin inflammation or infection on the face 5. Able to attend scheduled appointments and comply with all study requirements 6. Willing to participate in the study and provide signed informed consent

Exclusion criteria

Exclusion criteria: 1. Underlying medical conditions that affect inflammatory or wound healing processes, such as psoriasis, vitiligo, diabetes , Systemic Lupus Erythematosus (SLE), chronic kidney disease (stage 4 or higher), etc 2. Underlying medical conditions that cause abnormal skin pigmentation, such as Addison disease, hemochromatosis, etc 3. Immunocompromised states, such as bone marrow failure, or taking more than 15 mg/day of prednisolone, etc 4. History of skin cancer 5. Active skin infection or inflammation in the intended treatment area 6. Wounds or open sores on the face in the intended treatment area 7. Presence of more than 5 inflammatory acne lesions on both sides of the face 8. History of keloid scarring 9. Pregnant or currently breastfeeding 10. History of allergy to local anesthetics

Design outcomes

Primary

MeasureTime frame
Wrinkle baseline and at 1,2,3 month after the treatment Anthera 3D machine

Secondary

MeasureTime frame
Static wrinkle baseline and at 1,2,3 month after the treatment Merz aesthetic scales for evaluation of crow feet at rest (MAS),global aesthetic improvement score (GAIS) baseline and at 1,2,3 month after the treatment global aesthetic improvement score (GAIS),Texture baseline and at 1,2,3 month after the treatment Anthera 3D machine,Patient sastisfaction baseline and at 1,2,3 month after the treatment Visual analog scale

Countries

Thailand

Contacts

Public ContactChinathip Theerawattanawit

Division of Dermatology, Department of Medicine Faculty of Medicine, Ramathibodi Hospital

chinathipt@hotmail.com0863873788

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026